REQUEST A DEMO
Total
USD $0.00
Search more companies

Evotek-Mirai Genomiks OOO (Эвотэк-Мирай Геномикс ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Evotek-Mirai Genomiks OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Evotek-Mirai Genomiks OOO (Эвотэк-Мирай Геномикс ООО) is an enterprise in Russia, with the main office in Tatarstan Republc. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on March 03, 2017. The company’s latest financial report indicates a net sales revenue increase of 6% in 2024. Its’ total assets recorded a negative growth of 18.32%. In, 2024, the company’s net profit margin decreased by 214.12%.

Headquarters
Bolishie Kabany, Vystavochnaya, 1A, 1000
Tatarstan Republc; Tatarstan Republic; Postal Code: 422623

Contact Details: Purchase the Evotek-Mirai Genomiks OOO (Эвотэк-Мирай Геномикс ООО) report to view the information.

Basic Information
Financial Auditors:
Purchase the Evotek-Mirai Genomiks OOO (Эвотэк-Мирай Геномикс ООО) report to view the information.
Incorporation Date:
March 03, 2017
Company Performance
Financial values in the chart are available after Evotek-Mirai Genomiks OOO (Эвотэк-Мирай Геномикс ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
6%
Total operating revenue
6%
Operating profit (EBIT)
-45.87%
Net Profit (Loss) for the Period
-87.99%
Total Assets
-18.32%
Total Equity
-17.78%
Operating Profit Margin (ROS)
-120.78%
Net Profit Margin
-214.12%
Return on Equity (ROE)
-11.56%
Quick Ratio
11.49%
Cash Ratio
1.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?